Related Experiment Video
Updated: Jul 15, 2026

04:09
Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
Published on: September 20, 2024
The ongoing debate in thyroid surgery: should frozen section analysis be omitted?
Ozer Makay1, Gokhan Icoz, Baris Gurcu
1Ege University, School of Medicine, Department of General Surgery, Bornova, Izmir, Turkey.
Endocrine Journal
|April 13, 2007
Summary
Frozen section (FS) analysis aids intraoperative decision-making in thyroid cancer surgery, improving malignancy detection rates. Routine FS is recommended, except when fine-needle aspiration biopsy (FNAB) confirms malignancy.
Area of Science:
- Surgical Pathology
- Oncology
- Diagnostic Cytology
Background:
- The utility of frozen section (FS) in intraoperative decision-making for thyroid nodules remains debated.
- Accurate intraoperative assessment is crucial for determining appropriate surgical management of thyroid malignancies.
Purpose of the Study:
- To evaluate the role of intraoperative frozen section (FS) analysis in guiding surgical decisions for thyroid cancer.
- To assess the diagnostic accuracy and cost-effectiveness of FS in detecting thyroid malignancies in Turkey.
Main Methods:
- Retrospective analysis of 178 patients who underwent surgery for thyroid cancer between January 1996 and August 2004.
- Intraoperative frozen section (FS) analysis was performed on all evaluated patients.
- Comparison of FS results with final histopathology and assessment of changes in surgical strategy.
Main Results:
- Intraoperative FS correctly identified malignancy in 58.4% of cases, altering surgical strategy in 27.6% of these.
- The sensitivity of FS (58.4%) was significantly higher than fine-needle aspiration biopsy (FNAB) (22.5%) for thyroid cancer.
- False negative FS results increased the cost per informative FS from €25 to €42.7.
Conclusions:
- Intraoperative frozen section (FS) plays a valuable role in the surgical assessment of thyroid nodules, enhancing diagnostic accuracy.
- Routine use of FS is recommended for operative assessment, with potential omission only if FNAB definitively indicates malignancy.
- Despite limitations, FS remains a relevant tool in managing thyroid cancer, contrary to suggestions of its diminishing role.
